When doctors sell products
06 Feb 2023
These situations blur the boundaries between a therapeutic relationship and a commercial relationship. A patient may feel pressured to purchase; financial gain may distort a doctor’s judgement of the patient’s best interests; and the trust between doctor and patient may be undermined.
Honesty and transparency
The Medical Board’s Code of Conduct covers conflicts of interest (10.12) and financial and commercial dealings (10.13), including:
A conflict of interest in medical practice arises when a doctor, entrusted with acting in the interests of a patient, also has financial, professional or personal interests, or relationships with third parties, which may affect their care of the patient… They require identification, careful consideration, appropriate disclosure and accountability.
…
Doctors must be honest and transparent in financial arrangements with patients. Good medical practice involves:
... declaring to your patients your professional and financial interest in any product you might endorse or sell from your practice, and not making an unjustifiable profit from the sale or endorsement.
It would be reasonable to inform patients of your profit verbally if discussing a product, and in writing as part of an online product listing. An unjustifiable profit might involve a price above the recommended retail price, if one exists. Also, inform the patient where else they can purchase the product. If the product is part of a patient’s clinical treatment, document this in the medical records.
A Queensland GP was reprimanded and had conditions imposed on her registration in 2019 after she failed to disclose a conflict of interest for recommending a particular product and involving a patient in a marketing scheme.
Safety and efficacy
Before selling products to patients:
- satisfy yourself that any scientific claims are authoritative (e.g., from peer-reviewed journals)
- consult the literature independently rather than rely on the manufacturer’s claims
- inform the patient if there is little scientific evidence for the product, and document this in the medical records
- be alert to potential drug interactions
- stay up to date with the product’s scheduling status with the Therapeutic Goods Administration (TGA).
Advertising
- Making claims of a scientific nature must be accompanied by appropriate evidence for such claims – see Ahpra’s Acceptable evidence in health advertising.
- If a product you’re selling is a ‘therapeutic good’ (as opposed to cosmetic) or is advertised using claims of a therapeutic nature, advertising must comply with therapeutic goods regulation – see the TGA’s Advertising hub.
- You should be familiar with the Australian Competition and Consumer Commission’s information for medical professionals about the Competition and Consumer Act.
Insurance coverage
Seek advice as to whether you need product liability insurance. Your Professional Indemnity or Practice Indemnity Policy may have an exclusion in relation to indemnity for matters arising out of supply of goods and products.
Reference:
1.Parker MH, Wardle JL & Stewart CL (2011) Medical merchants: conflict of interest, product sales and notifiable conduct. MJA 194(1):34-37: mja.com.au/journal/2011/194/1/medical-merchants-conflict-interest-office-product-sales-and-notifiable-conduct
Stay updated with the latest medico-legal content |
Subscribe to MDA National’s biannual Member publication, Defence Update, for the latest medico-legal updates, articles and case studies.
Doctors Let's Talk: Get Yourself A Fricking GP
Get yourself a fricking GP stat! is a conversation with Dr Lam, 2019 RACGP National General Practitioner of the Year, rural GP and GP Anesthetics trainee, that explores the importance of finding your own GP as a Junior Doctor.
25 Oct 2022
Systematic efforts to reduce harms due to prescribed opioids – webinar recording
Efforts are underway across the healthcare system to reduce harms caused by pharmaceutical opioids. This 43-min recording of a live webinar, delivered 11 March 2021, is an opportunity for prescribers to check, and potentially improve, their contribution to these endeavours. Hear from an expert panel about recent opioid reforms by the Therapeutic Goods Administration and changes to the Pharmaceutical Benefits Scheme.
14 May 2021
Diplomacy in a hierarchy: tips for approaching a difficult conversation
Have you found yourself wondering how to broach a tough topic of conversation? It can be challenging to effectively navigate a disagreement with a co-worker, especially if they're 'above' you; however, it's vital for positive team dynamics and safe patient care. In this recording of a live webinar you'll have the opportunity to learn from colleagues' experiences around difficult discussions and hear from a diverse panel moderated by Dr Kiely Kim (medico-legal adviser and general practitioner). Recorded live on 2 September 2020.
05 Oct 2020